Loading…
Loading…
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Payments provider ACI Worldwide is reportedly considering a sale of its billing business. That's according to a report Friday (July 17) by Reuters, citing three sources familiar with the matter.
BOISE, Idaho--(BUSINESS WIRE)--Albertsons® Companies, Inc. (NYSE: ACI) and Albertsons Companies Foundation (“The Foundation”) today announced the results of the inaugural “Nourish the American Dream,” a first-of-its-kind nationwide campaign to help end childhood hunger across the United States. Together with more than 300 nonprofit partners, customers and communities, the campaign generated more than $12.2 million in support for childhood hunger relief nationwide, surpassing its original $5 mil.
BOISE, Idaho--(BUSINESS WIRE)--Albertsons® Companies, Inc. (NYSE: ACI) (the “Company”) today announced its Board of Directors has declared a cash dividend for the second quarter of fiscal 2026 of $0.17 per share of common stock. The cash dividend is payable on Aug. 7, 2026, to stockholders of record as of the close of business on July 24, 2026. About Albertsons Companies Albertsons Companies is a leading food and drug retailer in the United States. As of Feb. 28, 2026, the Company operated 2,24.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
AC Immune Reports Interim 12-Month Data from Phase 1b/2 ABATE Trial of ACI-24 in Prodromal Alzheimer's Disease ACI-24 anti-Abeta active immunotherapy generally safe and well tolerated in first three Alzheimer's disease (AD) cohorts in ABATE Anti-Abeta antibody dose-response demonstrated with antibodies detected at all dose levels in cohorts AD1-3 Ongoing AD4 cohort includes additional adjuvant designed to enhance ACI-24 responses Lausanne, Switzerland, June 30, 2026 -- AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision therapeutics for neurodegenerative diseases, today announced interim data from the first three cohorts (AD1, AD2 & AD3) of 74 patients with prodromal Alzheimer's disease (AD) in the Phase 1b/2 ABATE trial following 12 months of treatment with ACI-24 anti-amyloid beta (Abeta) active immunotherapy. In the trial to date, ACI-24 has been generally safe and well tolerated, with no evidence of amyloid-related imaging abnormalities-edema (ARIA-E).
For investors looking to build a defensive hedge within a diversified portfolio, these attractively valued consumer food stocks may deserve a closer look.
Albertsons has launched a new integration with commerce intelligence platform Criteo. The partnership, announced Thursday (June 25) by the grocery giant's retail media arm Albertsons Media Collective, is designed to bring product discovery into Albertsons artificial intelligence-powered conversational search.
Full call transcripts — prepared remarks + analyst Q&A — with speaker-by-speaker formatting and one-click switching across every quarter on file.
Click below to see what's inside, then upgrade to read every transcript for ACI and 80,000+ other tickers.
Transcripts source: company-published earnings calls. Speaker attribution and formatting are processed in-app.